Systematic Assessment of Treatment Effectiveness for Long-Term Management of Stable Atrial Tachycardia in Inpatient and Outpatient Environments

NCT07239804 · tracked via the Priya Life Science Germany tracker

Sponsor

Evangelical Hospital Düsseldorf

Phase

Observational

Started

2024-01-01

Last updated

2025-11-20

Condition(s) studied

Atrial TachycardiaStrokeMortalityAtrial Flutter

Study summary

The aim is to analyze long-term outcomes in a multicenter observational registry including patients undergoing atrial tachycardia rhythm control.

Eligibility

Sex

ALL

Min age

18 Years

Max age

—

Healthy volunteers

Inclusion Criteria: Patients undergoing atrial tachycardia rhythm control Exclusion Criteria: Follow-up \<30 days after atrial tachycardia rhythm control

Primary outcome measure(s)

Mortality, stroke and cardiovascular hospitalization — From AT rhythm control through study completion, an average of 2 years

Trial sites (5)

Facility	City	Region
EVK Düsseldorf	Düsseldorf	Germany
Asklepios Hospital St. Georg	Hamburg	Germany
University Hospital Hamburg-Eppendorf	Hamburg	Germany
Municipal Clinical Center Karlsruhe	Karlsruhe	Germany
University Hospital Münster	Münster	Germany

More Evangelical Hospital Düsseldorf trials in Germany

Optimizing Quality of Life by Improved Patient Expectation Following Atrial Fibrillation Catheter Ablation Recruiting

Ablation of Consecutive Atrial Tachycardia Recruiting

Other trials for the same condition

Master Study Protocol for the Cohort of the Specialist Network Stroke (SN Stroke)(Stroke-CORE) Starting soon

Clinical Cohort Study - TRUST Recruiting

Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG Recruiting

Prognostic Factors to Regain Consciousness Recruiting

CHAMPION-AF Clinical Trial Active, not recruiting

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07239804 on ClinicalTrials.gov ↗ ← All trials in Germany